title: Automation of complex assays: pharmacogenetics of warfarin dosing.
abstract: AutoGenomics, Inc. (Carlsbad, CA, USA) have developed a multiplex microarray assay for genotyping both VKORC1 and CYP2C9 using the INFINITI(™) Analyzer. Multiple alleles in each DNA sample are analyzed by polymerase chain reaction amplification, followed by detection primer extension using the INFINITI Analyzer. The INFINITI Analyzer performs single-nucleotide polymorphism (SNP) analysis using universal oligonucleotides immobilized on the biochip. To genotype broader ethnic groups, genomic DNA from whole blood was tested for nine SNPs for VKORC1 and six for CYP2C9 genotypes. Information related to all 15 SNPs is needed to determine dosing of population of diverse ethnic origin. The INFINITI system provides genotyping information for same day dosing of warfarin.
authors.affiliation: AutoGenomics, Inc., 2251 Rutherford Road, Carlsbad, CA 92008, USA +1 760 804 7378 Extn. 340; +1 760 804 7382; wwu@autogenomics.com.
authors.forename: Whei-Kuo
authors.initials: WK
authors.lastname: Wu
authors.forename: Paul G
authors.initials: PG
authors.lastname: Hujsak
authors.forename: Fareed
authors.initials: F
authors.lastname: Kureshy